Predictors, treatment, and outcomes of gastrojejunostomy stricture after gastric bypass for morbid obesity.
BACKGROUND
The aims of this study were to determine the rate of gastrojejunostomy (GJ) stricture following Roux-en-Y gastric bypass (RYGBP), the independent predictors of stricture, and clinical outcomes with and without a stricture.


METHODS
Univariate and multivariate analysis of peri-operative and outcomes data were prospectively collected from 379 morbidly obese patients who underwent consecutive open or laparoscopic RYGBP from January 2003 to August 2006. Predictors studied were age, gender, BMI, co-morbidities, surgical technique (hand-sewn vs linear stapler vs 21-mm vs 25-mm circular stapler; open vs laparoscopic; retrocolic retrogastric vs antecolic antegastric Roux limb course, and Roux limb length), and surgeon experience. Outcomes studied consisted of occurrence of GJ strictures, technical details and outcomes after endoscopic therapy, and excess weight loss (EWL) at 12 months.


RESULTS
15 patients (4.1%) developed a GJ stricture. The use of a 21-mm circular stapler was identified as the only independent predictor of a GJ stricture (odds ratio 11.3; 95% CI 2.2-57.4, P = 0.004). Endoscopic dilation relieved stricture symptoms in all patients (60% one dilation only). There was no significant difference in %EWL at 12 months between the patients with a stricture (median EWL 54%, IQR 49-63) vs. those without a stricture (median EWL 61%, ent predictor of GJ stricture. Endoscopic dilation relieved symptoms in all patients. Weight loss is independent of the anastomotic technique used and occurrence of a GJ stricture.
Takata
Mark C
MC
Department of Surgery, University of California San Francisco, San Francisco, CA 941430790, USA.
Ciovica
Ruxandra
R
Cello
John P
JP
Posselt
Andrew M
AM
Rogers
Stanley J
SJ
Campos
Guilherme M
GM
D000293:Adolescent; D000328:Adult; D000368:Aged; D002404:Catheterization; D015331:Cohort Studies; D003251:Constriction, Pathologic / Q000209:etiology / Q000628:therapy; D005260:Female; D015390:Gastric Bypass / Q000009:adverse effects*; D006801:Humans; D007579:Jejunal Diseases / Q000209:etiology* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D012307:Risk Factors; D016896:Treatment Outcome